CELEX: 62021CN0606
Language: en
Date: 2021-09-30 00:00:00
Title: Case C-606/21: Request for a preliminary ruling from the Cour d’appel de Paris (France) lodged on 30 September 2021 — Doctipharma SAS v Union des Groupements de pharmaciens d’officine (UDGPO), Pictime SAS operating under the name ‘Coreyre’

20.12.2021   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 513/23
            
         
      Request for a preliminary ruling from the Cour d’appel de Paris (France) lodged on 30 September 2021 — Doctipharma SAS v Union des Groupements de pharmaciens d’officine (UDGPO), Pictime SAS operating under the name ‘Coreyre’
      (Case C-606/21)
      (2021/C 513/33)
      Language of the case: French
      
         Referring court
      
      Cour d’appel de Paris
      
         Parties to the main proceedings
      
      
         Applicant: Doctipharma SAS
      
         Defendants: Union des Groupements de pharmaciens d’officine (UDGPO), Pictime SAS operating under the name ‘Coreyre’
      
         Questions referred
      
      
                  —
               
               
                  Is Doctipharma’s activity which is conducted on and from its website www.doctipharma.fr, to be regarded as an ‘information society service’ within the meaning of Directive 98/34/EC of the European Parliament and of the Council of 22 June 1998? (1)
                  
               
            
                  —
               
               
                  If so, does Doctipharma’s activity, which is conducted on and from its website www.doctipharma.fr, fall within the scope of Article 85c of the European Directive of 6 November 2011, (2) as amended by the Directive of 8 June 2011?
               
            
                  —
               
               
                  Is Article 85c of the Directive of 6 November 2001, as amended by the Directive of 8 June 2011, to be interpreted as meaning that the prohibition, based on an interpretation of Articles L. 5125-25 and L. 5125-26 of the Public Health Code, of Doctipharma’s activity, which is conducted on and from its website www.doctipharma.fr, constitutes a restriction justified by public health protection?
               
            
                  —
               
               
                  If not, is Article 85c of the Directive of 6 November 2011, as amended by the Directive of 8 June 2011, to be interpreted as meaning that it allows Doctipharma’s activity, which is conducted on and from its website www.doctipharma.fr?
               
            
                  —
               
               
                  In that situation, is the prohibition of Doctipharma’s activity, based on the interpretation by the Cour de cassation (Court of Cassation) of Articles L. 5125-25 and L. 5125-26 of the Public Health Code, justified by public health protection within the meaning of Article 85c of the Directive of 6 November 2001, as amended by the Directive of 8 June 2011?
               
            
                  —
               
               
                  If not, is Article 85c of the Directive of 6 November 2001, as amended by the Directive of 8 June 2011, to be interpreted as allowing the activity of an ‘information society service’ offered by Doctipharma?
               
            
         (1)  Directive 98/34/EC of the European Parliament and of the Council of 22 June 1998 laying down a procedure for the provision of information in the field of technical standards and regulations (OJ 1998 L 204, p. 37).
      
         (2)  Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ 2001 L 311, p. 67).